Onderzoeker
Mathieu Spaas
- Disciplines:Morfologische wetenschappen
Affiliaties
- Vakgroep Structuur en Herstel van de Mens (Departement)
Lid
Vanaf1 dec 2018 → Heden
Publicaties
1 - 7 van 7
- Microbiome and metabolome dynamics during radiotherapy for prostate cancer(2023)
Auteurs: Willeke Danckaert, Mathieu Spaas, Nora Sundahl, Aurélie De Bruycker, Valerie Fonteyne, Ellen De Paepe, Carlos De Wagter, Lynn Vanhaecke, Piet Ost
- Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial(2023)
Auteurs: Mathieu Spaas, Nora Sundahl, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer, Fréderic Duprez, Yolande Lievens, Veerle Surmont, Lieve Brochez, Dries Reynders, et al.
Pagina's: 1205 - 1213 - Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature(2022)
Auteurs: Willeke Danckaert, Mathieu Spaas, Piet Ost
Pagina's: 64 - 69 - Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial(2021)Volume: 161
Auteurs: Mathieu Spaas, Nora Sundahl, VIBEKE KRUSE, Daan De Maeseneer, Piet Dirix, Robin Van den Begin, Dirk Van Gestel, Vincent Renard, D Reynders, Els Goetghebeur, et al.
Pagina's: S490 - S491 - Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures(2021)
Auteurs: Annabel Meireson, Simon Tavernier, Sofie Van Gassen, Nora Sundahl, Annelies Demeyer, Mathieu Spaas, Vibeke Kruse, Liesbeth Ferdinande, Jo Van Dorpe, Benjamin Hennart, et al.
- Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial(2021)
Auteurs: Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Daan De Maeseneer, Annabel Meireson, Lieve Brochez, Dries Reynders, Els Goetghebeur, Robbe Van den Begin, et al.
- A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy(2021)
Auteurs: Miha Orazem, Cedric Draulans, Mathieu Spaas, Eric Van Cutsem, Marina Debecker, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans
Pagina's: 1121 - 1125